s6y CAS MEDICAL SYSTEMS INC 10-Q

CAS MEDICAL SYSTEMS INC 10-Q, filed Nov 8, 2016: IDEA: XBRL DOCUMENT

Inventories, Property and Equipment, and Intangible and Other Assets
9 Months Ended
Sep. 30, 2016
Inventories Property And Equipment And Intangible And Other Assets  
4. Inventories, Property and Equipment, and Intangible and Other Assets

Inventories consist of:

    September 30,     December 31,  
    2016     2015  
             
Raw materials   $ 886,222     $ 919,870  
Work-in-process     16,812       20,917  
Finished goods     291,092       487,638  
Total   $ 1,194,126     $ 1,428,425  

 

Property and equipment are stated at cost and are depreciated using the straight-line method over the estimated useful lives of the assets.  Property and equipment include FORE-SIGHT cerebral oximetry monitors primarily located at customer sites within the United States.  Such equipment, categorized as "Equipment at Customers", is typically held under a no-cost program whereby customers purchase disposable sensors for use with the Company's FORE-SIGHT equipment.  Under this program, the Company retains title to the monitors shipped to its customers and amortizes the monitors using the straight-line method over their estimated useful lives.

Intangible assets consist of patents issued, patents pending, trademarks, and purchased technology which are recorded at cost. Patents are amortized on a straight-line basis over 20 years. Capitalized costs are amortized over their estimated useful lives.

Intangible and other assets consist of the following:

 

    September 30,     December 31,  
    2016     2015  
             
Patents and other assets   $ 925,602     $ 905,454  
Patents pending     320,483       315,826  
      1,246,085       1,221,280  
Accumulated amortization     (462,283 )     (408,263 )
Total   $ 783,802     $ 813,017  

 

Amortization expense of intangible and other assets for the nine months ended September 30, 2016, was $54,020. Estimated amortization expense for the calendar year 2016 is $69,823. Expected amortization expense of intangible and other assets for the next five calendar years and beyond follows:

 

2017   $ 36,100  
2018     32,500  
2019     28,500  
2020     28,000  
2021     27,700  
Thereafter     556,700  
    $ 709,500  

 

The Company reviews its intangible and other assets for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company believes that the carrying amounts of its remaining long-lived assets are fully recoverable.